Bionik Laboratories Corp announces it has entered into an exclusive distribution agreement for the sale of its InMotion Robotic System in South Korea with Curexo. It also becomes the exclusive distributor of Curexo’s Morning Walk lower body rehabilitation technology within the United States.
Bionik’s InMotion Robotic System includes the InMotion ARM, InMotion HAND, and InMotion WRIST.
The Morning Walk is a gait training robot designed for people with walking impairments due to injury or illness. It features a body weight support system that unloads the patient using an adjustable saddle seat design. The Morning Walk also provides varied and progressively challenging walking experiences such as floor, ramp, and stair walking, and works with interactive virtual reality software.
“We are excited to enter into this agreement with Curexo, and to expand our global footprint throughout Asia and into South Korea. We are optimistic about the Morning Walk’s prospects and committed to creating a long-term partnership with Curexo,” says Dr Eric Dusseux, chief executive officer of Toronto-based Bionik Laboratories, in a media release.
“We are pleased to partner with Bionik for distribution of our robotics systems in the US, as they are a recognized industry leader in the rehabilitation market and have a history of successful business relationships within the country,” states Jung SH, Chief Technology Officer, Curexo.
[Source(s): Bionik Laboratories Corp, PR Newswire]